This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Feb. 28, 2013 /PRNewswire/ -- Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis centered around its patented therapeutic protein MANF, today announced that Dr.
John W. Commissiong, Chief Scientific Officer, will be presenting data generated in six hydroxydopamine (6-OHDA) rodent models of Parkinson's disease at the 15
th Annual Meeting of the American Society for Experimental NeuroTherapeutics (ASENT) in
Washington, DC on
March 1st, 2013. The meeting is being held
February 28 –
March 2, 2013 at the Hyatt Regency in
"There is tremendous interest in our progress in Parkinson's disease research, and I look forward to meeting with leading researchers and industry professionals to discuss the important results we are seeing in our studies with MANF," said Dr. Commissiong. "ASENT is an outstanding forum to interact with colleagues, and stay apprised of the latest research in this field."
The American Society for Experimental NeuroTherapeutics is an independent non-profit organization established in 1997 by leaders in academia, government, advocacy and industry to facilitate the process by which new therapies are made available to patients with neurological disorders. Its primary goal is to encourage and advance the development of improved therapies for diseases and disorders of the nervous system.
ASENT engages in scientific exchanges to encourage contacts between those involved in the discovery and development of neurotherapeutics and to provide opportunities for dialogue between the interested groups. The society organizes education and training and publishes a journal for healthcare practitioners, scientists and officials participating in the neurotherapeutics field, which serves as a forum for its members and interested groups addressing diverse issues.